Filing Details
- Accession Number:
- 0001415889-19-001357
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-21 19:52:20
- Reporting Period:
- 2019-11-20
- Accepted Time:
- 2019-11-21 19:52:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1411685 | Vistagen Therapeutics Inc. | VTGN | Pharmaceutical Preparations (2834) | 205093315 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1415876 | Ralph H. Snodgrass | C/O Vistagen Therapeutics, Inc. 343 Allerton Avenue South San Francisco CA 94080 | Pres./Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-20 | 15,000 | $0.34 | 15,000 | No | 4 | P | Indirect | By H. Ralph Snodgrass Living Trust, dated 10/2/2008 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By H. Ralph Snodgrass Living Trust, dated 10/2/2008 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 62,724 | Direct |
Billionaire Hedge Funds
